The approval of booster shots for immune-compromised patients is likely to kick-off a temporary surge in new jabs, but when could more individuals need another shot?
The approval of booster shots for immune-compromised patients is likely to kick-off a temporary surge in new jabs, but when could more individuals need another shot?